Deoxycoformycin-induced response in chronic lymphocytic leukaemia: deoxyadenosine toxicity in non-replicating lymphocytes

British Journal of Haematology
R F Kefford, R M Fox

Abstract

The occurrence of severe immunodeficiency disease in children with inherited adenosine deaminase deficiency, and reports of remission induction in T-cell acute lymphoblastic leukaemia with the adenosine deaminase inhibitor deoxycoformycin, prompted a study of the effects of deoxyadenosine on resting peripheral blood lymphocytes (PBL) and chronic lymphocytic leukaemic (CLL) lymphocytes in short-term culture. In the presence of an inhibitor of adenosine deaminase, micromolar concentrations of dAdo caused elevation of deoxyadenosine-5'-triphosphate (dATP) pools and in vitro lysis of non-dividing PBL and CLL lymphocytes. This death of non-replicating cells indicates a mechanism of deoxyadenosine toxicity independent of DNA replication and ribonucleotide reductase inhibition. Similar changes occurred in vivo in a patient with advanced CLL who responded to treatment with deoxycoformycin, 0.1 mg/kg, days 1-5, with a fall in the WCC from 102.0 x 10(9)/1 to 6.8 x 10(9)/l over 21 d. Therapeutic blockade of deoxyadenosine catabolism deserves further investigation both in the treatment of lymphoproliferative disease and as a method lympholytic immunosuppression.

References

Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·D A CarsonJ E Seegmiller
Jan 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·A CohenD W Martin
May 10, 1979·Journal of Immunological Methods·M Madsen, H E Johnsen
Apr 1, 1975·European Journal of Clinical Investigation·M H TattersallA V Hoffbrand
Oct 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·M F SiawJ J Hutton
Oct 1, 1980·Biochemical Medicine·C A KollerB S Mitchell
Oct 1, 1981·European Journal of Cancer & Clinical Oncology·R F KeffordM H Tattersall

❮ Previous
Next ❯

Citations

Oct 1, 1996·Cancer·T al-TweigeriJ R Mackey
Jan 1, 1985·Cancer Chemotherapy and Pharmacology·A R BelchL W Brox
Jan 1, 1991·Journal of Inherited Metabolic Disease·E TakedaM Miyao
Oct 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·W N ValentineR Brockway
Feb 1, 1985·The Journal of Clinical Investigation·S SetoD A Carson
Mar 25, 2000·Drugs & Aging·N Kalil, B D Cheson
Jul 1, 1986·British Journal of Haematology·J B JohnstonL G Israels
Jan 18, 2006·Survey of Ophthalmology·Katharina E SchmidSusanne Binder
Jan 23, 2004·Leukemia·M Pastor-AngladaJ Gil
Jan 1, 1985·Archives of Dermatological Research·A R Ahmed
Jan 1, 1984·Scandinavian Journal of Haematology·L J HallamM G Whiteside
Feb 5, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Donatella AldinucciValter Gattei
Sep 15, 1985·Biochemical Pharmacology·F W BurgessR E Parks
May 16, 1984·Biochemical and Biophysical Research Communications·L BroxA Belch

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.